Literature DB >> 10404328

Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area.

R Geisel, F J Schmitz, L Thomas, G Berns, O Zetsche, B Ulrich, A C Fluit, H Labischinsky, W Witte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10404328     DOI： 10.1093/jac/43.6.846

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  19 in total

1.  Lack of evidence for involvement of hypermutability in emergence of vancomycin-intermediate Staphylococcus aureus.

Authors:  Alexander J O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 2.  Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.

Authors:  Catherine Liu; Henry F Chambers
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

Review 3.  Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates.

Authors:  Sebastiaan J van Hal; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

4.  VISA, hetero-VISA and VRSA: the end of the vancomycin era?

Authors:  John M Conly; B Lynn Johnston
Journal:  Can J Infect Dis       Date:  2002-09

5.  First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.

Authors:  S Trakulsomboon; S Danchaivijitr; Y Rongrungruang; C Dhiraputra; W Susaemgrat; T Ito; K Hiramatsu
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus.

Authors:  Franziska Schaaff; Andrea Reipert; Gabriele Bierbaum
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

7.  Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study.

Authors:  A C Fluit; C L Wielders; J Verhoef; F J Schmitz
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 8.  Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance: clinical significance and treatment options.

Authors:  M J Rybak; R L Akins
Journal:  Drugs       Date:  2001       Impact factor: 9.546

9.  Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.

Authors:  T R Walsh; A Bolmström; A Qwärnström; P Ho; M Wootton; R A Howe; A P MacGowan; D Diekema
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

10.  Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.

Authors:  Andrea Reipert; Kerstin Ehlert; Thomas Kast; Gabriele Bierbaum
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.